Reactions have continued to trail the approval of Yeztugo, a twice-yearly injectable medication for HIV prevention, with experts warning that its high cost could shut out millions of vulnerable people worldwide.
Trending
- Smallholders unable to afford essential farm inputs, expert says
- Farmers say high costs drive up catfish prices
- NEWSAN calls for urgent repairs to sewage systems
- Rising feed costs push farmers out of business
- Naira slips to ₦1,379.99/$ as interbank FX turnover tops $500m
- FAAC shares ₦2.44trn October revenue as statutory, VAT receipts decline
- State trains veterinarians to expand rural services
- UniCal Alumni turn to agribusiness to tackle graduate unemployment
